INTUITIVE SURGICAL INC (IUI1.DE) Stock Price, Forecast & Analysis

FRA:IUI1 • US46120E6023

416.7 EUR
+0.45 (+0.11%)
Last: Feb 17, 2026, 07:00 PM

IUI1.DE Key Statistics, Chart & Performance

Key Statistics
Market Cap147.98B
Revenue(TTM)10.06B
Net Income(TTM)2.86B
Shares355.13M
Float352.88M
52 Week High572.5
52 Week Low341.55
Yearly DividendN/A
Dividend Yield0%
EPS(TTM)7.53
PE55.34
Fwd PE48.33
Earnings (Next)04-20
IPO2000-06-13
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
IUI1.DE short term performance overview.The bars show the price performance of IUI1.DE in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -5 -10

IUI1.DE long term performance overview.The bars show the price performance of IUI1.DE in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 20 -20 40 60 80

The current stock price of IUI1.DE is 416.7 EUR. In the past month the price decreased by -9.34%. In the past year, price decreased by -28.94%.

INTUITIVE SURGICAL INC / IUI1 Daily stock chart

IUI1.DE Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating
IUI1.DE Full Technical Analysis Report

IUI1.DE Fundamental Analysis

ChartMill assigns a fundamental rating of 7 / 10 to IUI1.DE. Both the health and profitability get an excellent rating, making IUI1.DE a very profitable company, without any liquidiy or solvency issues.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
IUI1.DE Full Fundamental Analysis Report

IUI1.DE Financial Highlights

Over the last trailing twelve months IUI1.DE reported a non-GAAP Earnings per Share(EPS) of 7.53. The EPS increased by 21.83% compared to the year before.


Industry RankSector Rank
PM (TTM) 28.38%
ROA 13.96%
ROE 16.02%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%14.48%
Sales Q2Q%18.76%
EPS 1Y (TTM)21.83%
Revenue 1Y (TTM)20.51%
IUI1.DE financials

IUI1.DE Forecast & Estimates

42 analysts have analysed IUI1.DE and the average price target is 533.68 EUR. This implies a price increase of 28.07% is expected in the next year compared to the current price of 416.7.

For the next year, analysts expect an EPS growth of 14.46% and a revenue growth 15.92% for IUI1.DE


Analysts
Analysts78.1
Price Target533.68 (28.07%)
EPS Next Y14.46%
Revenue Next Year15.92%
IUI1.DE Analyst EstimatesIUI1.DE Analyst Ratings

IUI1.DE Ownership

Ownership
Inst Owners88.29%
Ins Owners0.45%
Short Float %N/A
Short RatioN/A
IUI1.DE Ownership

IUI1.DE Competitors/Peers

The largest stocks on the EU markets in the "Health Care Equipment" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
2M6 MEDTRONIC PLC15.75109.407B
1MDT MEDTRONIC PLC16.18108.304B
SHL SIEMENS HEALTHINEERS AG15.2746.169B
1PHIA KONINKLIJKE PHILIPS NV17.3825.46B
PHIA KONINKLIJKE PHILIPS NV17.2224.921B
PHI1 KONINKLIJKE PHILIPS NV17.1924.882B
BIM BIOMERIEUX18.4810.913B
DIA DIASORIN SPA16.374.014B
OBCK OTTOBOCK SE & CO KGAA17.933.702B
AFX CARL ZEISS MEDITEC AG - BR11.442.311B

About IUI1.DE

Company Profile

IUI1 logo image Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. The company is headquartered in Sunnyvale, California. The company went IPO on 2000-06-13. The firm specializes in invasive care and robotic-assisted surgery. Its technologies include the da Vinci surgical systems and the Ion endoluminal system. The da Vinci surgical system is designed to enable surgeons to perform a range of surgical procedures within its targeted general surgery, urologic, gynecologic, cardiothoracic, and head and neck specialties and consists of a surgeon's console or consoles, a patient-side cart, and a high-performance vision system. The Ion endoluminal system is a flexible, robotic-assisted, catheter-based platform for which the cleared indication is minimally invasive biopsies in the lung and consists of a system cart, a controller, a catheter, and a vision probe. Its Ion system extends its commercial offering beyond surgery into diagnostic and endoluminal procedures.

Company Info

INTUITIVE SURGICAL INC

1020 Kifer Road

Sunnyvale CALIFORNIA US

Employees: 15638

IUI1 Company Website

IUI1 Investor Relations

Phone: 13026587581

INTUITIVE SURGICAL INC / IUI1.DE FAQ

Can you describe the business of INTUITIVE SURGICAL INC?

Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. The company is headquartered in Sunnyvale, California. The company went IPO on 2000-06-13. The firm specializes in invasive care and robotic-assisted surgery. Its technologies include the da Vinci surgical systems and the Ion endoluminal system. The da Vinci surgical system is designed to enable surgeons to perform a range of surgical procedures within its targeted general surgery, urologic, gynecologic, cardiothoracic, and head and neck specialties and consists of a surgeon's console or consoles, a patient-side cart, and a high-performance vision system. The Ion endoluminal system is a flexible, robotic-assisted, catheter-based platform for which the cleared indication is minimally invasive biopsies in the lung and consists of a system cart, a controller, a catheter, and a vision probe. Its Ion system extends its commercial offering beyond surgery into diagnostic and endoluminal procedures.


Can you provide the latest stock price for INTUITIVE SURGICAL INC?

The current stock price of IUI1.DE is 416.7 EUR. The price increased by 0.11% in the last trading session.


What is the dividend status of INTUITIVE SURGICAL INC?

IUI1.DE does not pay a dividend.


What is the ChartMill technical and fundamental rating of IUI1 stock?

IUI1.DE has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 7 out of 10.


On which exchange is IUI1.DE stock listed?

IUI1.DE stock is listed on the Frankfurt Stock Exchange exchange.


What is the expected growth for IUI1 stock?

The Revenue of INTUITIVE SURGICAL INC (IUI1.DE) is expected to grow by 15.92% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.